Canada markets open in 1 hour 44 minutes

Blueprint Medicines Corporation (BPMC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
94.86+3.52 (+3.85%)
At close: 04:00PM EDT
99.97 +5.11 (+5.39%)
Pre-Market: 07:30AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.96B
Enterprise Value 5.58B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)23.04
Price/Book (mrq)45.62
Enterprise Value/Revenue 22.38
Enterprise Value/EBITDA -11.86

Trading Information

Stock Price History

Beta (5Y Monthly) 0.65
52-Week Change 362.40%
S&P500 52-Week Change 323.57%
52 Week High 3101.00
52 Week Low 343.89
50-Day Moving Average 390.85
200-Day Moving Average 370.87

Share Statistics

Avg Vol (3 month) 3813.91k
Avg Vol (10 day) 3722.1k
Shares Outstanding 562.81M
Implied Shares Outstanding 661.23M
Float 860.56M
% Held by Insiders 10.86%
% Held by Institutions 1105.10%
Shares Short (Apr 15, 2024) 44.25M
Short Ratio (Apr 15, 2024) 45.9
Short % of Float (Apr 15, 2024) 49.32%
Short % of Shares Outstanding (Apr 15, 2024) 46.93%
Shares Short (prior month Mar 15, 2024) 45.15M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -203.30%
Operating Margin (ttm)-146.07%

Management Effectiveness

Return on Assets (ttm)-25.34%
Return on Equity (ttm)-157.13%

Income Statement

Revenue (ttm)249.38M
Revenue Per Share (ttm)4.12
Quarterly Revenue Growth (yoy)85.50%
Gross Profit (ttm)N/A
EBITDA -474.61M
Net Income Avi to Common (ttm)-506.98M
Diluted EPS (ttm)-8.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)710.64M
Total Cash Per Share (mrq)11.61
Total Debt (mrq)774.12M
Total Debt/Equity (mrq)592.70%
Current Ratio (mrq)3.76
Book Value Per Share (mrq)2.14

Cash Flow Statement

Operating Cash Flow (ttm)-436.85M
Levered Free Cash Flow (ttm)-239.41M